Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

  • Home Blog Tag Myelodysplastic syndrome market

Myelodysplastic Syndrome Market

Dec 03, 2024

FDA Grants Fast Track for Lin BioScience’s LBS-007; Alnylam’s AMVUTTRA sNDA Under Review; FDA Approves RAPIBLYK for Atrial Fibrillation; Applied Therapeutics Receives CRL for Govorestat in Galactosemia; R289 Gets Fast Track for Lower-Risk MDS.

Nov 13, 2023

Servier’s Tibsovo Opens The Door To A New Era In The Battle Against Myelodysplastic Syndromes

Sep 15, 2023

Myelodysplastic Syndrome Treatment Market: Unveiling the Robust Pipeline

Newsletter/Whitepaper